BIOGEN INC. (BIIB)
Biological Products, (No Diagnostic Substances) · Healthcare · $25.8B
Intrinsic Value (Consensus)
$144.86
Current Price
$175.80
Margin of Safety
-17.6%
17.6% Above Intrinsic Value
Value: $145
Price: $176
Valuation Model Estimates
Current Price: $175.80
DCF (Discounted Cash Flow)
$177.12
Graham Number
$141.20
Earnings Power Value
$85.34
Relative Value (P/E)
$175.80
Dividend Discount Model
Not applicable
—
Consensus Value
$144.86
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $8.79
- EPS (Forward)
- $8.97
- Book Value
- $100.81
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 8.7%
- Debt/Equity
- 42%
- Revenue Growth
- 2.2%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance